Accurately assessing suicidal ideation and behavior (SIB) is a critical and often required element in many clinical trials. To successfully identify SIB, it’s important to provide as many modes of administration as possible so that all stakeholders — clinical sites, investigators, clinicians, and patients — have access to options that meet their unique needs and preferences.
This study provides empirical support for the use of the patient-reported, text-based eC-SSRS in clinical trials, further demonstrating that multiple modes could be used in the same study and that data can be pooled across modes. This provides an important new eC-SSRS option that can advance the systematic measurement of SIB.
Click here to read the full article.